NCT06275958: DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer
- State
- Under way
- Phase
- Phase 3
- People
- 587 planned
- Started
- 1 Jul 2024
- Primary completion
- Jun 2028
- Arms
- Doublet therapy, dose-reduced (low toxicity risk based on G8)
- Results
- None posted
- 23 Feb 2024: Trial registered
- 1 Jul 2024: Trial started